Articles
Phosphagenics completes IND-enabling pain patch study
Phosphagenics (ASX:POH) achieved encouraging results from the first of two planned IND-enabling phase I trials of pain patch TPM/oxymorphone. [ + ]
World-first computer chip inspired by the human brain
Scientists from IBM have unveiled the first neurosynaptic computer chip to achieve an unprecedented scale of 1 million programmable spiking neurons, 256 million programmable synapses and 46 billion synaptic operations per second per watt. [ + ]
Clinuvel rejects $95m takeover offer
Clinuvel (ASX:CUV) has declined a takeover bid from US-based Retrophin, with the board electing to focus the company's efforts on pursuing EMA approval for Scenesse in skin condition EPP. [ + ]
Australia needs a new innovation policy, claims AVCAL
The Australian Private Equity and Venture Capital Association has provided a submission to the Senate Economics References Committee's inquiry into Australia's innovation system, claiming Australia is in urgent need of a new national innovation policy to ensure we have a highly dynamic and modern economy in the future. [ + ]
Finding markers for inflammation and auto-immunity
Professor Mark Hogarth has spent most of his career studying the role of Fc receptors in inflammatory and auto-immune disorders. Found on the surface of a variety of immune cells, these antibody-binding receptors are now prospective targets for new treatments of inflammation, therapeutic monoclonal antibodies in cancer and manipulation in vaccines for HIV-AIDS. [ + ]
Cochlear net grows 32% thanks to new products
Cochlear (ASX:COH) grew its 2H14 profit by 32% and sales by 28% as the company launched new additions to each of its product categories. [ + ]
Tescan minerals analyser purchased for WA research centre
X-ray tube supplier AXT has been competitively selected to provide a Tescan Integrated Minerals Analyser (TIMA) to the John de Laeter Centre (JDLC) at Curtin University in Western Australia. [ + ]
Pharmaxis sues NovaQuest over financing deal breach
Pharmaxis (ASX:PXS) is taking NovaQuest to court, seeking a reinstatement of the US$40 million financing arrangement covering commercialisation of Bronchitol in the EU and US. [ + ]
European cancer research could be at risk
The European Society For Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients. [ + ]
Ambassador for science
A passionate advocate for science, Professor Lyn Beazley shares some of the exceptional and continuing contributions she has made to Australian science over a career that began with a passion for biology. [ + ]
UTS boffins develop blood test for oral cancers
Researchers from UTS have developed a fast and easy way to administer a blood test for detecting early warning signs of oral cancers. [ + ]
ResMed wins sales ban against APEX in Germany
A German court has issued an injunction prohibiting Taiwan's APEX Medical from local sales of two face masks found to infringe on ResMed (ASX:RMD) patents. [ + ]
Patrys commences CAR T cell research program
Patrys (ASX:PAB) has started collaborative research into genetically engineering T cells against novel anticancer targets using its IgM antibodies. [ + ]
Biotron's BIT225 reverses immune impairment in HIV
New data from a trial of Biotron's (ASX:BIT) BIT225 in HIV show that patients treated daily demonstrated a reduction in sCD163 levels in the blood. [ + ]
Brocade to handle genome facility's big data
Driven by the growth of genomic data sets, the Australian Genome Research Facility is deploying a high-performance 10 Gigabit Ethernet (GbE) core network across its entire estate, with its Melbourne node the first to go live with new switching infrastructure from Brocade. [ + ]
